Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Introduction of a polynucleotide molecule into or...
Reexamination Certificate
2006-07-11
2006-07-11
Housel, James C. (Department: 1648)
Chemistry: molecular biology and microbiology
Process of mutation, cell fusion, or genetic modification
Introduction of a polynucleotide molecule into or...
C435S325000, C435S352000, C435S358000, C435S361000, C435S366000, C435S320100, C536S023500
Reexamination Certificate
active
07074616
ABSTRACT:
The present invention pertains to a DNA encoding a polypeptide comprising an entire sequence of the amino acid sequence as shown by SEQ ID NO:2 of Sequence Listing or a partial sequence thereof, or a polypeptide comprising the polypeptide described above, wherein any of the polypeptides has an activity of a receptor capable of binding to a murine PBSF/SDF-1; a polypeptide encoded by the DNA described above, wherein the polypeptide has an activity of a receptor capable of binding to a murine PBSF/SDF-1; cells expressing the polypeptide described above and a human CD4 protein; and a method of screening an AIDS onset inhibitor or an HIV-1 infection inhibitor, characterized by the use of the cells described above. According to the present invention, there can be provided a novel murine CXC chemokine receptor gene, a method of screening an HIV-1 infection inhibitor, and the like, each of which is useful in studies of a therapeutic agent for AIDS and the functional mechanism of HIV-1 infection.
REFERENCES:
patent: WO 97/28258 (1997-08-01), None
Bowie et al., Science, vol. 24, pp. 1306-1310 (1990).
Bieniasz et al., Journal of Virology, vol. 71 No. 9, pp. 7097-7100 (Sep. 1997).
Lorez et al., Aids Research and Human Retroviruses, vol. 8 No. 12, pp. 2063-2071 (1992).
Ashorn et al., Journal of Virology, vol. 64, pp. 2149-2156 (1990).
Database EMBL, EBI Online, Hinxton, Cambridgeshire, U.K., Database accession No. D99581 (XP002223233), abstract of Moepps et al., “M. musculus gene enclding leukocyte-derived seven transmembrane domain receptor, strain B6” (Nov. 1, 1996).
Database EMBL, EBI Online, Hinxton, Cambridgeshire, U.K., Database accession No. D87747 (XP002223286), abstract of T. Nagasawa, “Mus musculus mRNA for murine CXCR-4, complete cds.”, Jan. 12, 1997.
Joanne F. Berson et al., J. Virol., vol. 70, No. 9, pp. 6288-6295, Sep. 1996.
Nagasawa, Takashi et al., Proc. Natl. Acad. Sci. USA, 1996, 93 (25), 14726-14729.
Heesen, Michael et al., J. Immunol., 1996, 157(12), 5455-5460.
Estelle Oberlin et al.; Letters to Nature; vol. 382; 1996; pp. 833-835; XP002028004.
Alignment of DNAs encoding mouse and human CXCR-4; EMBOSS-Align; Matrix DNA full, no date available.
Y. Feng et al., Science, vol. 272, (1996), pp. 872-877.
Iizasa Hisashi
Kishimoto Tadamitsu
Nagasawa Takashi
Nakajima Toshihiro
Tachibana Kazunobu
Birch & Stewart Kolasch & Birch, LLP
Housel James C.
Kishimoto Tadamitsu
Lucas Zachariah
Shionogi & Co. Ltd.
LandOfFree
Mouse CXC chemokine receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mouse CXC chemokine receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mouse CXC chemokine receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3559637